Examination of fully automated mammographic density measures using LIBRA and breast cancer risk in a cohort of 21,000 non-Hispanic white women.


Journal

Breast cancer research : BCR
ISSN: 1465-542X
Titre abrégé: Breast Cancer Res
Pays: England
ID NLM: 100927353

Informations de publication

Date de publication:
06 08 2023
Historique:
received: 05 04 2023
accepted: 09 07 2023
medline: 8 8 2023
pubmed: 7 8 2023
entrez: 6 8 2023
Statut: epublish

Résumé

Breast density is strongly associated with breast cancer risk. Fully automated quantitative density assessment methods have recently been developed that could facilitate large-scale studies, although data on associations with long-term breast cancer risk are limited. We examined LIBRA assessments and breast cancer risk and compared results to prior assessments using Cumulus, an established computer-assisted method requiring manual thresholding. We conducted a cohort study among 21,150 non-Hispanic white female participants of the Research Program in Genes, Environment and Health of Kaiser Permanente Northern California who were 40-74 years at enrollment, followed for up to 10 years, and had archived processed screening mammograms acquired on Hologic or General Electric full-field digital mammography (FFDM) machines and prior Cumulus density assessments available for analysis. Dense area (DA), non-dense area (NDA), and percent density (PD) were assessed using LIBRA software. Cox regression was used to estimate hazard ratios (HRs) for breast cancer associated with DA, NDA and PD modeled continuously in standard deviation (SD) increments, adjusting for age, mammogram year, body mass index, parity, first-degree family history of breast cancer, and menopausal hormone use. We also examined differences by machine type and breast view. The adjusted HRs for breast cancer associated with each SD increment of DA, NDA and PD were 1.36 (95% confidence interval, 1.18-1.57), 0.85 (0.77-0.93) and 1.44 (1.26-1.66) for LIBRA and 1.44 (1.33-1.55), 0.81 (0.74-0.89) and 1.54 (1.34-1.77) for Cumulus, respectively. LIBRA results were generally similar by machine type and breast view, although associations were strongest for Hologic machines and mediolateral oblique views. Results were also similar during the first 2 years, 2-5 years and 5-10 years after the baseline mammogram. Associations with breast cancer risk were generally similar for LIBRA and Cumulus density measures and were sustained for up to 10 years. These findings support the suitability of fully automated LIBRA assessments on processed FFDM images for large-scale research on breast density and cancer risk.

Sections du résumé

BACKGROUND
Breast density is strongly associated with breast cancer risk. Fully automated quantitative density assessment methods have recently been developed that could facilitate large-scale studies, although data on associations with long-term breast cancer risk are limited. We examined LIBRA assessments and breast cancer risk and compared results to prior assessments using Cumulus, an established computer-assisted method requiring manual thresholding.
METHODS
We conducted a cohort study among 21,150 non-Hispanic white female participants of the Research Program in Genes, Environment and Health of Kaiser Permanente Northern California who were 40-74 years at enrollment, followed for up to 10 years, and had archived processed screening mammograms acquired on Hologic or General Electric full-field digital mammography (FFDM) machines and prior Cumulus density assessments available for analysis. Dense area (DA), non-dense area (NDA), and percent density (PD) were assessed using LIBRA software. Cox regression was used to estimate hazard ratios (HRs) for breast cancer associated with DA, NDA and PD modeled continuously in standard deviation (SD) increments, adjusting for age, mammogram year, body mass index, parity, first-degree family history of breast cancer, and menopausal hormone use. We also examined differences by machine type and breast view.
RESULTS
The adjusted HRs for breast cancer associated with each SD increment of DA, NDA and PD were 1.36 (95% confidence interval, 1.18-1.57), 0.85 (0.77-0.93) and 1.44 (1.26-1.66) for LIBRA and 1.44 (1.33-1.55), 0.81 (0.74-0.89) and 1.54 (1.34-1.77) for Cumulus, respectively. LIBRA results were generally similar by machine type and breast view, although associations were strongest for Hologic machines and mediolateral oblique views. Results were also similar during the first 2 years, 2-5 years and 5-10 years after the baseline mammogram.
CONCLUSION
Associations with breast cancer risk were generally similar for LIBRA and Cumulus density measures and were sustained for up to 10 years. These findings support the suitability of fully automated LIBRA assessments on processed FFDM images for large-scale research on breast density and cancer risk.

Identifiants

pubmed: 37544983
doi: 10.1186/s13058-023-01685-6
pii: 10.1186/s13058-023-01685-6
pmc: PMC10405373
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

92

Subventions

Organisme : NCI NIH HHS
ID : R01 CA166827
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA168893
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA237541
Pays : United States
Organisme : NIA NIH HHS
ID : RC2 AG036607
Pays : United States
Organisme : NCI NIH HHS
ID : R01 CA264987
Pays : United States

Informations de copyright

© 2023. BioMed Central Ltd., part of Springer Nature.

Références

Boyd NF, Rommens JM, Vogt K, Lee V, Hopper JL, Yaffe MJ, Paterson AD. Mammographic breast density as an intermediate phenotype for breast cancer. Lancet Oncol. 2005;6(10):798–808.
doi: 10.1016/S1470-2045(05)70390-9 pubmed: 16198986
McCormack VA, dos Santos SI. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159–69.
doi: 10.1158/1055-9965.EPI-06-0034
Sickles EA, D'Orsi CJ, Bassett LW, Appleton CM, Berg WA, Burnside ES, Feig SA, Gavenonis SC, Newell MS, Trinh MM. ACR BI-RADS mammography. In: vACR BI-RADS atlas, breast imaging reporting and data system. Reston, VA: American College of Radiology; 2013.
Byrne C, Schairer C, Wolfe J, Parekh N, Salane M, Brinton LA, Hoover R, Haile R. Mammographic features and breast cancer risk: effects with time, age, and menopause status. J Natl Cancer Inst. 1995;87(21):1622–9.
doi: 10.1093/jnci/87.21.1622 pubmed: 7563205
Lee-Han H, Cooke G, Boyd NF. Quantitative evaluation of mammographic densities: a comparison of methods of assessment. Eur J Cancer Prev. 1995;4(4):285–92.
doi: 10.1097/00008469-199508000-00003 pubmed: 7549820
Saftlas AF, Hoover RN, Brinton LA, Szklo M, Olson DR, Salane M, Wolfe JN. Mammographic densities and risk of breast cancer. Cancer. 1991;67(11):2833–8.
doi: 10.1002/1097-0142(19910601)67:11<2833::AID-CNCR2820671121>3.0.CO;2-U pubmed: 2025849
Nguyen TL, Choi YH, Aung YK, Evans CF, Trinh NH, Li S, Dite GS, Kim MS, Brennan PC, Jenkins MA, et al. Breast cancer risk associations with digital mammographic density by pixel brightness threshold and mammographic system. Radiology. 2018;286(2):433–42.
doi: 10.1148/radiol.2017170306 pubmed: 29040039
Habel LA, Lipson JA, Achacoso N, Rothstein JH, Yaffe MJ, Liang RY, Acton L, McGuire V, Whittemore AS, Rubin DL, et al. Case-control study of mammographic density and breast cancer risk using processed digital mammograms. Breast Cancer Res. 2016;18(1):53.
doi: 10.1186/s13058-016-0715-3 pubmed: 27209070 pmcid: 4875652
Gastounioti A, Kasi CD, Scott CG, Brandt KR, Jensen MR, Hruska CB, Wu FF, Norman AD, Conant EF, Winham SJ, et al. Evaluation of LIBRA software for fully automated mammographic density assessment in breast cancer risk prediction. Radiology. 2020;296(1):24–31.
doi: 10.1148/radiol.2020192509 pubmed: 32396041
Fowler EE, Vachon CM, Scott CG, Sellers TA, Heine JJ. Automated percentage of breast density measurements for full-field digital mammography applications. Acad Radiol. 2014;21(8):958–70.
doi: 10.1016/j.acra.2014.04.006 pubmed: 25018067 pmcid: 4166439
Busana MC, Eng A, Denholm R, Dowsett M, Vinnicombe S, Allen S, Dos-Santos-Silva I. Impact of type of full-field digital image on mammographic density assessment and breast cancer risk estimation: a case-control study. Breast Cancer Res. 2016;18(1):96.
doi: 10.1186/s13058-016-0756-7 pubmed: 27670914 pmcid: 5037867
Dench E, Bond-Smith D, Darcey E, Lee G, Aung YK, Chan A, Cuzick J, Ding ZY, Evans CF, Harvey J, et al. Measurement challenge: protocol for international case-control comparison of mammographic measures that predict breast cancer risk. BMJ Open. 2019;9(12): e031041.
doi: 10.1136/bmjopen-2019-031041 pubmed: 31892647 pmcid: 6955467
Byng JW, Boyd NF, Fishell E, Jong RA, Yaffe MJ. The quantitative analysis of mammographic densities. Phys Med Biol. 1994;39(10):1629–38.
doi: 10.1088/0031-9155/39/10/008 pubmed: 15551535
Highnam R, Brady SM, Yaffe MJ, Karssemeijer N, Harvey J. Robust breast composition measurement—VolparaTM. In: 2010; Berlin, Heidelberg: Springer. 2010. p. 342–349.
Astley SM, Harkness EF, Sergeant JC, Warwick J, Stavrinos P, Warren R, Wilson M, Beetles U, Gadde S, Lim Y, et al. A comparison of five methods of measuring mammographic density: a case-control study. Breast Cancer Res. 2018;20(1):10.
doi: 10.1186/s13058-018-0932-z pubmed: 29402289 pmcid: 5799922
Alexeeff SE, Odo NU, McBride R, McGuire V, Achacoso N, Rothstein JH, Lipson JA, Liang RY, Acton L, Yaffe MJ, et al. Reproductive factors and mammographic density: associations among 24,840 women and comparison of studies using digitized film-screen mammography and full-field digital mammography. Am J Epidemiol. 2019;188(6):1144–54.
doi: 10.1093/aje/kwz033 pubmed: 30865217 pmcid: 6545283
Giorgi Rossi P, Djuric O, Helin V, Astley S, Mantellini P, Nitrosi A, Harkness EF, Gauthier E, Puliti D, Balleyguier C, et al. Validation of a new fully automated software for 2D digital mammographic breast density evaluation in predicting breast cancer risk. Sci Rep. 2021;11(1):19884.
doi: 10.1038/s41598-021-99433-3 pubmed: 34615978 pmcid: 8494838
Keller BM, Chen J, Daye D, Conant EF, Kontos D. Preliminary evaluation of the publicly available Laboratory for Breast Radiodensity Assessment (LIBRA) software tool: comparison of fully automated area and volumetric density measures in a case-control study with digital mammography. Breast Cancer Res. 2015;17:117.
doi: 10.1186/s13058-015-0626-8 pubmed: 26303303 pmcid: 4549121
Sieh W, Rothstein JH, Klein RJ, Alexeeff SE, Sakoda LC, Jorgenson E, McBride RB, Graff RE, McGuire V, Achacoso N, et al. Identification of 31 loci for mammographic density phenotypes and their associations with breast cancer risk. Nat Commun. 2020;11(1):5116.
doi: 10.1038/s41467-020-18883-x pubmed: 33037222 pmcid: 7547012
Kvale MN, Hesselson S, Hoffmann TJ, Cao Y, Chan D, Connell S, Croen LA, Dispensa BP, Eshragh J, Finn A, et al. Genotyping informatics and quality control for 100,000 subjects in the genetic epidemiology research on adult health and aging (GERA) cohort. Genetics. 2015;200(4):1051–60.
doi: 10.1534/genetics.115.178905 pubmed: 26092718 pmcid: 4574249
Keller BM, Nathan DL, Wang Y, Zheng Y, Gee JC, Conant EF, Kontos D. Estimation of breast percent density in raw and processed full field digital mammography images via adaptive fuzzy c-means clustering and support vector machine segmentation. Med Phys. 2012;39(8):4903–17.
doi: 10.1118/1.4736530 pubmed: 22894417 pmcid: 3416877
Conant EF, Keller BM, Pantalone L, Gastounioti A, McDonald ES, Kontos D. Agreement between breast percentage density estimations from standard-dose versus synthetic digital mammograms: results from a large screening cohort using automated measures. Radiology. 2017;283(3):673–80.
doi: 10.1148/radiol.2016161286 pubmed: 28121523

Auteurs

Laurel A Habel (LA)

Division of Research, Kaiser Permanente Northern California, CA, Oakland, USA. laurel.habel@kp.org.

Stacey E Alexeeff (SE)

Division of Research, Kaiser Permanente Northern California, CA, Oakland, USA.

Ninah Achacoso (N)

Division of Research, Kaiser Permanente Northern California, CA, Oakland, USA.

Vignesh A Arasu (VA)

Division of Research, Kaiser Permanente Northern California, CA, Oakland, USA.
Department of Radiology, Kaiser Permanente Northern California, Vallejo, CA, USA.

Aimilia Gastounioti (A)

Mallinckrodt Institute of Radiology, Washington University School of Medicine, Saint Louis, MO, USA.

Lawrence Gerstley (L)

Division of Research, Kaiser Permanente Northern California, CA, Oakland, USA.

Robert J Klein (RJ)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Rhea Y Liang (RY)

Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.

Jafi A Lipson (JA)

Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.

Walter Mankowski (W)

Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Laurie R Margolies (LR)

Department of Diagnostic, Molecular and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Joseph H Rothstein (JH)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Daniel L Rubin (DL)

Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA.
Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.

Li Shen (L)

Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, NY, New York, USA.
Department of Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Adriana Sistig (A)

Department of Artificial Intelligence and Human Health, Icahn School of Medicine at Mount Sinai, NY, New York, USA.

Xiaoyu Song (X)

Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Marvella A Villaseñor (MA)

Division of Research, Kaiser Permanente Northern California, CA, Oakland, USA.

Mark Westley (M)

Division of Research, Kaiser Permanente Northern California, CA, Oakland, USA.

Alice S Whittemore (AS)

Department of Biomedical Data Science, Stanford University School of Medicine, Stanford, CA, USA.
Department of Epidemiology and Population Health, Stanford University School of Medicine, Stanford, CA, USA.

Martin J Yaffe (MJ)

Sunnybrook Research Institute and Department of Medical Biophysics, University of Toronto, Toronto, ON, Canada.

Pei Wang (P)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Despina Kontos (D)

Department of Radiology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Weiva Sieh (W)

Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Population Health Science and Policy, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Department of Epidemiology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH